These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 14612515)
1. Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer. Risques RA; Moreno V; Ribas M; Marcuello E; Capellà G; Peinado MA Cancer Res; 2003 Nov; 63(21):7206-14. PubMed ID: 14612515 [TBL] [Abstract][Full Text] [Related]
2. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737 [TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related]
5. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Rodriguez J; Frigola J; Vendrell E; Risques RA; Fraga MF; Morales C; Moreno V; Esteller M; Capellà G; Ribas M; Peinado MA Cancer Res; 2006 Sep; 66(17):8462-9468. PubMed ID: 16951157 [TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
7. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers. Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
9. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma. Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227 [TBL] [Abstract][Full Text] [Related]
10. Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. Bocker T; Schlegel J; Kullmann F; Stumm G; Zirngibl H; Epplen JT; Rüschoff J J Pathol; 1996 May; 179(1):15-9. PubMed ID: 8691338 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Georgiades IB; Curtis LJ; Morris RM; Bird CC; Wyllie AH Oncogene; 1999 Dec; 18(56):7933-40. PubMed ID: 10637503 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [TBL] [Abstract][Full Text] [Related]
13. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH. Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339 [TBL] [Abstract][Full Text] [Related]
14. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up. Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas. Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399 [TBL] [Abstract][Full Text] [Related]
16. [Genetic pathways in colorectal cancer: interest for the pathologist]. Piard F; Martin L; Chapusot C; Ponnelle T; Faivre J Ann Pathol; 2002 Sep; 22(4):277-88. PubMed ID: 12410150 [TBL] [Abstract][Full Text] [Related]
17. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations. Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889 [TBL] [Abstract][Full Text] [Related]
18. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Chang SC; Lin JK; Lin TC; Liang WY Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226 [TBL] [Abstract][Full Text] [Related]
19. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability. Fernández-Peralta AM; Nejda N; Oliart S; Medina V; Azcoita MM; González-Aguilera JJ Cancer Genet Cytogenet; 2005 Feb; 157(1):18-24. PubMed ID: 15676142 [TBL] [Abstract][Full Text] [Related]